Insmed (INSM) Capital Expenditures (2011 - 2026)

Insmed has reported Capital Expenditures for 16 years, with the latest figure at $6.3 million in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 73.62% year-over-year to $6.3 million in Q2 2026; TTM through Jun 2026 was $28.7 million, a 43.83% decrease from a year earlier, with the FY2025 full-year figure at $32.6 million, up 48.52% from the prior year.
• Capital Expenditures was $6.3 million for Q2 2026 at Insmed, up from $3.5 million in the prior quarter.
• The five-year high for Capital Expenditures was $30.8 million in Q3 2024, with the low at -$20.4 million in Q2 2024.
• Average Capital Expenditures over 5 years is $6.1 million, with a median of $5.7 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Capital Expenditures surged 443.86% in 2023, then slumped 768.13% in 2024.
• Over 5 years, Capital Expenditures stood at $12.2 million in 2022, then plunged by 74.07% to $3.2 million in 2023, then surged by 113.7% to $6.8 million in 2024, then soared by 144.96% to $16.6 million in 2025, then slumped by 62.27% to $6.3 million in 2026.
• The last three Capital Expenditures figures came in at $6.3 million (Q2 2026), $3.5 million (Q1 2026), and $16.6 million (Q4 2025), per Business Quant data.